Fig. 1.
H90 and A3D8 anti-CD44 mAbs inhibit proliferation of HL60, NB4, THP-1, and KG1a cell lines.
A total of 105 cells/mL were seeded into 96-well plates and incubated in triplicate in the presence of specific anti-CD44 mAbs (2.5 μg/mL A3D8 or 20 μg/mL H90). Controls were cells incubated with isotypic control (20 μg/mL IgG1). At the indicated times, the viable cell number was determined using trypan blue dye exclusion (A). The statistical difference (P < .05) between A3D8-treated cells and controls is reached from day 2 (P < .05). The one between H90-treated cells and controls is reached from day 3 in HL60, NB4, and THP-1 cells and day 2 in KG1a cells. Treatment with the anti-CD44 mAb J173, which is inactive, gives similar results as the isotypic control. ▪: control; ▴: + H90; ■: +A3D8. At day 3 (exponential growth of control cells), [3H]thymidine incorporation into the cellular DNA was measured (B). Data are means ± 1 SD of 3 independent experiments. Data obtained with A3D8- or H90-treated cells are significantly different from those of controls (P < .05). Light grey bar: control; medium grey bar: +A3D8; black bar: + H90.